In a TNBS-induced colitis model, treatment with Lactobacillus peptidoglycan increased the number of Tregs in mesenteric lymph nodes and elevated IL-10 expression in the colonic mucosa, implying that NOD2 activity within the intestinal mucosa fosters a milieu conducive to immune tolerance. Here, IL10 is linked to colitis.